Brian Strem
Chief Executive Officer at KIORA PHARMACEUTICALS, INC.
Net worth: 49 488 $ as of 2024-04-29
Brian Strem active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Chief Executive Officer | 2021-07-25 | - |
| Director/Board Member | 2021-07-25 | - | |
| President | 2021-07-25 | - | |
| Comptroller/Controller/Auditor | 2022-06-15 | - | |
| Director of Finance/CFO | 2022-06-15 | - | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Director/Board Member | 2015-05-31 | - |
| Director of Finance/CFO | - | - | |
| Founder | - | - | |
| Corporate Secretary | - | - | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Director/Board Member | 2019-12-31 | - |
| Founder | 2019-12-31 | - | |
| Corporate Officer/Principal | - | - | |
| Bayon Therapeutics, Inc. | Director/Board Member | - | - |
| Founder | - | - |
Career history of Brian Strem
Training of Brian Strem
| Cornell University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Director/Board Member | 4 |
| Founder | 3 |
| Director of Finance/CFO | 2 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
Yellowbrick Bio LLC
Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Health Technology |
| Bayon Therapeutics, Inc. |
- Stock Market
- Insiders
- Brian Strem
- Experience
